Abstract
To evaluate the role of chemotherapy and radiation therapy in the treatment of pure germinomas of the central nervous system (CNS). We reviewed a historical cohort of 79 patients between the ages of 3–35 years who received definitive treatment for newly diagnosed, pure CNS germinoma between 1985 and 2010 at the University of California, San Francisco (UCSF). Median age at diagnosis was 15 years (interquartile range, IQR 12–20 years) and 61 (77.2 %) patients were male. Median follow-up for the cohort was 111.1 months (IQR 45.7–185.1 months). Five-year PFS rate was 86.4 % (95 % CI 76.1–92.4) and 5 year OS rate was 93.0 % (95 % CI 84.1–97.1). Median PFS was 104.6 months (IQR 41.4–170.1 months). Fourteen patients progressed and 8 died of their disease. Patients who received focal irradiation (XRT) and chemotherapy had a significantly higher rate of progression compared to those who received whole brain irradiation (WBI) or whole ventricle irradiation (WVI). Three of 8 patients had a PR to chemotherapy and received focal XRT progressed whereas only 1 of 9 patients who had a CR to chemotherapy who went on to receive focal XRT progressed. Elevation of hCGβ > 50 mIU/ml was not significantly associated with disease progression (HR 5.64, 95 % CI 0.97–32.7, p = 0.054). Patients treated with WBI or WVI with or without chemotherapy achieve better disease control compared to patients treated with focal XRT + chemotherapy.
Similar content being viewed by others
References
Packer RJ, Cohen BH, Cooney K (2000) Intracranial germ cell tumors. Oncologist 5(4):312–320
Echevarria ME, Fangusaro J, Goldman S (2008) Pediatric central nervous system germ cell tumors: a review. Oncologist 13(6):690–699
Aoyama H, Shirato H, Ikeda J, Fujieda K, Miyasaka K, Sawamura Y (2002) Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol 20(3):857–865
Fujimaki T (2009) Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical overview. J Child Neurol 24(11):1439–1445
Matsutani M (2009) Pineal germ cell tumors. Prog Neurol Surg 23:76–85
Calaminus G, Kortmann R, Worch J et al (2013) SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-oncology 15(6):788–796
Haas-Kogan DA, Missett BT, Wara WM et al (2003) Radiation therapy for intracranial germ cell tumors. Int J Radiat Oncol Biol Phys 56(2):511–518
Rogers SJ, Mosleh-Shirazi MA, Saran FH (2005) Radiotherapy of localised intracranial germinoma: time to sever historical ties? Lancet Oncol 6(7):509–519
Shikama N, Ogawa K, Tanaka S et al (2005) Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma: a multiinstitutional, retrospective review of 180 patients. Cancer 104(1):126–134
Alapetite C, Brisse H, Patte C et al (2010) Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro-oncology 12(12):1318–1325
Ogawa K, Shikama N, Toita T et al (2004) Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys 58(3):705–713
Lafay-Cousin L, Millar BA, Mabbott D et al (2006) Limited-field radiation for bifocal germinoma. Int J Radiat Oncol Biol Phys 65(2):486–492
Jensen AW, Laack NN, Buckner JC, Schomberg PJ, Wetmore CJ, Brown PD (2010) Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. Int J Radiat Oncol Biol Phys 77(5):1449–1456
Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H (1998) Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 34(1):104–110
Ogino H, Shibamoto Y, Takanaka T et al (2005) CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome. Int J Radiat Oncol Biol Phys 62(3):803–808
Finlay J, da Silva NS, Lavey R et al (2008) The management of patients with primary central nervous system (CNS) germinoma: current controversies requiring resolution. Pediatr Blood Cancer 51(2):313–316
Buckner JC, Peethambaram PP, Smithson WA et al (1999) Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J Clin Oncol 17(3):933–940
Kretschmar C, Kleinberg L, Greenberg M, Burger P, Holmes E, Wharam M (2007) Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the children’s oncology group. Pediatr Blood Cancer 48(3):285–291
Bouffet E, Baranzelli MC, Patte C et al (1999) Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Société Française d’Oncologie Pédiatrique. Br J Cancer 79(7–8):1199–1204
Matsutani M (2001) Combined chemotherapy and radiation therapy for CNS germ cell tumors–the Japanese experience. J Neurooncol 54(3):311–316
Matsutani M. Treatment of intracranial germ cell tumors: The second phase II study of Japanese GCT study group. Neuro-oncology. 2008;420
Kamoshima Y, Sawamura Y, Ikeda J, Shirato H, Aoyama H (2008) Late recurrence and salvage therapy of CNS germinomas. J Neurooncol 90(2):205–211
Von Rohr E, Gonner F, Schroth G, Cerny T (1999) Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapy. J Clin Neurosci 6(3):247–249
Acknowledgments
The work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant number KL2TR000143 (SM).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schoenfeld, A., Haas-Kogan, D.A., Molinaro, A. et al. Pure germinomas of the central nervous system: treatment strategies and outcomes. J Neurooncol 120, 643–649 (2014). https://doi.org/10.1007/s11060-014-1599-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-014-1599-7